| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.18 | 0.007 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |